capsaicin patch 8% Qutenza
Selected indexed studies
- Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. (J Pain, 2017) [PMID:27746370]
- Capsaicin 8% patch Qutenza and other current treatments for neuropathic pain in chemotherapy-induced peripheral neuropathy (CIPN). (Curr Opin Support Palliat Care, 2021) [PMID:33905384]
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. (Lancet Neurol, 2015) [PMID:25575710]
_Worker-drafted node — pending editorial review._
Connections
capsaicin patch 8% Qutenza is a side effect of
Sources
- Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis. (2025) pubmed
- Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. (2017) pubmed
- Capsaicin 8% patch Qutenza and other current treatments for neuropathic pain in chemotherapy-induced peripheral neuropathy (CIPN). (2021) pubmed
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. (2015) pubmed
- Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia. (2011) pubmed
- Capsaicin 8% Patch and Chronic Postsurgical Neuropathic Pain. (2021) pubmed
- Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. (2014) pubmed
- Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database. (2013) pubmed
- Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy. (2023) pubmed
- Capsaicin 8% patch reversibly reduces A-delta fiber evoked potential amplitudes. (2018) pubmed